MEI Pharma Inc (MEIP)
3.31
+0.11
(+3.44%)
USD |
NASDAQ |
Apr 17, 16:00
MEI Pharma Enterprise Value: -37.43M for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | -37.43M |
| April 16, 2024 | -38.16M |
| April 15, 2024 | -37.83M |
| April 12, 2024 | -37.69M |
| April 11, 2024 | -35.29M |
| April 10, 2024 | -34.43M |
| April 09, 2024 | -34.03M |
| April 08, 2024 | -33.96M |
| April 05, 2024 | -34.49M |
| April 04, 2024 | -33.16M |
| April 03, 2024 | -32.50M |
| April 02, 2024 | -32.83M |
| April 01, 2024 | -33.60M |
| March 28, 2024 | -32.83M |
| March 27, 2024 | -33.36M |
| March 26, 2024 | -33.76M |
| March 25, 2024 | -33.68M |
| March 22, 2024 | -33.96M |
| March 21, 2024 | -35.29M |
| March 20, 2024 | -35.63M |
| March 19, 2024 | -34.69M |
| March 18, 2024 | -34.69M |
| March 15, 2024 | -33.96M |
| March 14, 2024 | -33.36M |
| March 13, 2024 | -32.30M |
| Date | Value |
|---|---|
| March 12, 2024 | -31.83M |
| March 11, 2024 | -32.83M |
| March 08, 2024 | -34.16M |
| March 07, 2024 | -35.89M |
| March 06, 2024 | -34.89M |
| March 05, 2024 | -32.96M |
| March 04, 2024 | -31.23M |
| March 01, 2024 | -31.16M |
| February 29, 2024 | -31.83M |
| February 28, 2024 | -31.50M |
| February 27, 2024 | -31.63M |
| February 26, 2024 | -31.10M |
| February 23, 2024 | -30.76M |
| February 22, 2024 | -31.43M |
| February 21, 2024 | -29.23M |
| February 20, 2024 | -29.63M |
| February 16, 2024 | -30.23M |
| February 15, 2024 | -29.03M |
| February 14, 2024 | -28.10M |
| February 13, 2024 | -28.63M |
| February 12, 2024 | -26.90M |
| February 09, 2024 | -27.63M |
| February 08, 2024 | -28.83M |
| February 07, 2024 | -29.43M |
| February 06, 2024 | -28.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.34M
Minimum
Mar 28 2022
362.99M
Maximum
Jun 23 2020
57.13M
Average
68.10M
Median
Jan 28 2022
Enterprise Value Benchmarks
| Merck & Co Inc | 345.53B |
| United Therapeutics Corp | 8.779B |
| Macrogenics Inc | 775.97M |
| Voyager Therapeutics Inc | 189.41M |
| Moderna Inc | 31.00B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.06M |
| Total Expenses (Quarterly) | 11.93M |
| EPS Diluted (Quarterly) | -1.66 |
| Earnings Yield | 89.73% |
| Operating Earnings Yield | 166.6% |
| Normalized Earnings Yield | 184.66 |